MR: Analysis & Opinions

  1. J&J Files NDA for Combo Diabetes Drug - Analyst Blog

    December 14, 2012
    Janssen Research & Development, LLC, a part of the Johnson & Johnson (JNJ) family of companies, recently announced ...
  2. Stock Market News for December 14, 2012 - Market News

    December 14, 2012
    Investor apprehension about the Fiscal Cliff dilemma overshadowed couple of positive domestic reports and dragged ...
  3. Regal-Beloit Offers Common Stock - Analyst Blog

    December 13, 2012
    Headquartered in Beloit, Wisconsin, Regal-BeloitCorporation (RBC) recently issued a public offering of 2,750,000 ...
  4. Stock Market News for December 13, 2012 - Market News

    December 13, 2012
    Benchmarks lost most of the gains that were propelled by the central bank's announcement of a new stimulus plan and ...
  5. Myriad Teams Up with Sanofi - Analyst Blog

    December 11, 2012
    Myriad RBM, a wholly-owned subsidiary of molecular diagnostic company Myriad Genetics Inc. (MYGN), has recently ...
  6. Montpelier's Cat Loss Guidance - Analyst Blog

    December 11, 2012
    Montpelier Re Holdings Ltd. (MRH) expects fourth quarter 2012 pretax loss from Superstorm Sandy to approximate $95 ...
  7. Alexion Pharmaceuticals and Other Healthcare Stocks ...

    December 11, 2012
    The market has been doing well after the morning's trading. The Nasdaq has climbed 1.7%; the S&P 500 has increased ...
  8. Basic Materials Stocks, Including Potash ...

    December 11, 2012
    It's been a good morning for the market. The Nasdaq has risen 1.7%; the S&P 500 has climbed 1%; and the Dow has ...
  9. ACE Limited's Cat Loss Guidance - Analyst Blog

    December 11, 2012
    ACE Limited (ACE) expects loss from Superstorm Sandy to approximate $380 million after tax, net of reinsurance and ...
  10. Merck's Alzheimer's Drug Progresses - Analyst Blog

    December 10, 2012
    Merck (MRK) recently moved its Alzheimer's disease candidate, MK-8931, into a phase II/III study (EPOCH). The study ...
  11. Dejour farms out development of West Grand Valley - ...

    December 10, 2012
    Dejour farms out development of West Grand Valley By Steven Ralston, CFA Dejour Energy (DEJ) announced the ...
  12. Conoco Sets 2013 Capex at $15.8B - Analyst Blog

    December 10, 2012
    Texas-based ConocoPhillips (COP) intends to allocate $15.8 billion on capital projects in 2013, almost same as the ...
  13. Celgene and More Big Movers in Healthcare on December ...

    December 10, 2012
    On a good day for the market, the Nasdaq is trading up 0.6%, the S&P 500 is up 0.2% and the Dow has increased 0.3%. ...
  14. Broadcom's Analyst Day Supports The Bulls

    December 10, 2012
    Broadcom seems to be lengthening its lead on its wannabe rivals.
  15. Alexion Pharmaceuticals and More Big Movers in ...

    December 07, 2012
    So far today, the Nasdaq is down 0.7%, the S&P 500 is unchanged and the Dow is trading up 0.3%. The healthcare ...
  16. Alexion Pharmaceuticals and Other Big Movers on the ...

    December 07, 2012
    The Nasdaq has decreased 0.7%, the S&P 500 has remained steady and the Dow has climbed 0.3% so far today. The recent ...
  17. Freeport Snaps Up Plains, McMoRan - Analyst Blog

    December 07, 2012
    Mining giant Freeport-McMoRan Copper & Gold Inc. (FCX) has made a major stride to venture into the U.S. energy ...
  18. VRX and Gladerma Ink Revised Deal - Analyst Blog

    December 06, 2012
    Valeant Pharmaceuticals International, Inc. (VRX) recently announced that it has inked a revised North American ...
  19. Pharma & Biotech Stock Outlook - Dec 2012 - Zacks ...

    December 06, 2012
    The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
  20. Pharma & Biotech Stock Outlook - Dec 2012 - Industry Outlook

    December 06, 2012
    The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
Marketplace
Trading Center